Registry for assessing the effects of Upper Tract Urothelial Cancer
A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
This study is creating a registry to gather information and samples from patients with Upper Tract Urothelial Cancer to help improve understanding and treatment of the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT05438537 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a comprehensive registry for patients with Upper Tract Urothelial Cancer (UTUC) at Prince of Wales Hospital in Hong Kong. It will collect clinical information, treatment outcomes, and biological samples such as blood, urine, and tumor tissue to investigate new diagnostic and therapeutic agents. The goal is to better understand the epidemiology, natural history, and management of UTUC, addressing existing controversies and limitations in treatment approaches.
Who should consider this trial
Good fit: Ideal candidates include male patients over 18 years old who have UTUC and are awaiting surgery or have a history of UTUC with any prior interventions.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved management strategies and outcomes for patients with Upper Tract Urothelial Cancer.
How similar studies have performed: While UTUC is a less common condition, similar registries have shown promise in improving understanding and management of rare cancers, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients \> 18 years old * Patients who has presence of UTUC and pending for surgery * Patients who has history of UTUC with any intervention performed Exclusion Criteria: \- Patients fail to provide informed consent
Where this trial is running
Hong Kong
- Prince of Wales Hospital — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Jeremy Yuen-Chun TEOH, FRCS(Ed) MBBS — Chinese University of Hong Kong
- Study coordinator: Jeremy Yuen-Chun TEOH, FRCS(Ed)
- Email: jeremyteoh@surgery.cuhk.edu.hk
- Phone: 3505-2625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.